The scientific community has never gone from genomic sequencing to vaccine approvalas fast as it has with Covid-19. Now, health care leaders’ new challenge is to acquire thevaccines and roll out comprehensive vaccination programs that can help us achieveherd immunity. Fortunately, we can learn from past vaccination experiences and currentexpertise to proactively plan for the biggest likely hurdles to achieving that goal.

How to use this guide
We created this guide in collaboration with health system executives and internal expertsto help leaders pressure test the comprehensiveness of their vaccination planning efforts.This document describes the 11 biggest hurdles—covering regional coordination, resourceconstraints, and public willingness to receive vaccinations—that experts foresee makingvaccine rollouts more challenging. For each hurdle, we include a set of potential “blind spot”questions leaders may miss, which leaders can use to engage vaccine planning taskforces,partners, and other executives in identifying potential gaps in strategy. This informationshould be used as a supplement to, rather than a replacement for, any guidance youreceive from federal, state, or local officials.

What this guide does not include
This document focuses on ‘on-the-ground’ logistical and delivery hurdles that have ahigh likelihood of occurring, regardless of vaccine supply or approvals. It does not includepotential drug-related hurdles pertaining to vaccine efficacy, child safety, complicationrates, post-vaccination transmission rates, natural immunity longevity, or other vaccine specificfactors.

Download now